Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$327M |
| 2 |
Chipotle Mexican Grill
CMG
|
+$271M |
| 3 |
Chevron
CVX
|
+$264M |
| 4 |
JPMorgan Chase
JPM
|
+$233M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$707M |
| 2 |
Johnson & Johnson
JNJ
|
+$396M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
Walmart Inc
WMT
|
+$285M |
| 5 |
Intuitive Surgical
ISRG
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.73% |
| 2 | Technology | 14.98% |
| 3 | Financials | 10.9% |
| 4 | Consumer Discretionary | 8.96% |
| 5 | Real Estate | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Gorman-Rupp
GRC
$2.15B
| $4.67M | ﹤0.01% |
127,815
| – | – |
|
1852
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $4.66M | ﹤0.01% |
96,366
+15,000
| +18% | +$732K |
|
1853
Champions Oncology
CSBR
$76.4M
| $4.64M | ﹤0.01% |
265,846
+165,246
| +164% | +$1.47M |
|
1854
Avnet
AVT
$7.27B
| $4.63M | ﹤0.01% |
+103,300
| New | +$4.74M |
|
1855
Harvard Bioscience
HBIO
$27.1M
| $4.62M | ﹤0.01% |
87,970
+13,223
| +18% | +$742K |
|
|
ADAM
1856
Adamas Trust
ADAM
$813M
| $4.61M | ﹤0.01% |
189,475
+136,675
| +259% | +$3.42M |
|
|
PRO
1857
DELISTED
PROS Holdings
PRO
| $4.61M | ﹤0.01% |
+131,500
| New | +$4.94M |
|
|
BBL
1858
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $4.61M | ﹤0.01% |
+104,700
| New | +$4.51M |
|
|
COOP
1859
DELISTED
Mr. Cooper
COOP
| $4.6M | ﹤0.01% |
+275,882
| New | +$4.78M |
|
1860
V2X
VVX
$2.79B
| $4.59M | ﹤0.01% |
147,200
-97,600
| -40% | -$3.15M |
|
1861
The GEO Group
GEO
$4.1B
| $4.58M | ﹤0.01% |
+182,200
| New | +$4.66M |
|
|
MRTX
1862
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.58M | ﹤0.01% |
97,200
+92,600
| +2,013% | +$5.16M |
|
|
FENG
1863
Phoenix New Media
FENG
$18.3M
| $4.57M | ﹤0.01% |
180,665
-41,685
| -19% | -$1.1M |
|
1864
G. Willi-Food International
WILC
$401M
| $4.57M | ﹤0.01% |
642,600
+5,700
| +0.9% | +$39.8K |
|
|
ACBI
1865
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $4.56M | ﹤0.01% |
272,500
-42,900
| -14% | -$792K |
|
1866
Navios Maritime Partners
NMM
$2.28B
| $4.55M | ﹤0.01% |
173,413
+16,086
| +10% | +$473K |
|
1867
UTStarcom
UTSI
$22.9M
| $4.55M | ﹤0.01% |
296,074
-50
| -0% | -$762 |
|
1868
James Hardie Industries
JHX
$15.3B
| $4.54M | ﹤0.01% |
297,327
+14,400
| +5% | +$230K |
|
1869
Graco
GGG
$12.9B
| $4.53M | ﹤0.01% |
97,800
-332,300
| -77% | -$15.5M |
|
|
WDR
1870
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $4.53M | ﹤0.01% |
213,956
-29,483
| -12% | -$593K |
|
1871
Camden Property Trust
CPT
$11B
| $4.53M | ﹤0.01% |
+48,400
| New | +$4.5M |
|
|
EXPR
1872
DELISTED
Express, Inc.
EXPR
| $4.53M | ﹤0.01% |
20,470
-11,180
| -35% | -$2.29M |
|
|
ALTA
1873
DELISTED
Altabancorp
ALTA
| $4.52M | ﹤0.01% |
133,200
-19,000
| -12% | -$677K |
|
|
MITT
1874
TPG Mortgage Investment Trust
MITT
$222M
| $4.52M | ﹤0.01% |
82,867
+8,034
| +11% | +$457K |
|
|
CVLY
1875
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $4.52M | ﹤0.01% |
159,387
+1,330
| +0.8% | +$37.6K |
|
Similar funds
Renaissance Technologies's Q3 2018 Portfolio in Review
As of Q3 2018, Renaissance Technologies held 3,734 positions worth $97.3B, up 6% from $91.7B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Renaissance Technologies's Q3 2018 filing shows 508 new, 1,623 increased, 1,169 reduced and 410 closed positions. Its largest new stake was JPMorgan Chase: 2,054,913 shares worth $232M. The largest sale was Apple, an estimated $707M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q3 2018 buy was JPMorgan Chase: 2,054,913 shares worth $232M.
- Renaissance Technologies added most to Twenty-First Century Fox, Inc. Class A in Q3 2018, an estimated $327M increase.
- Renaissance Technologies's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $396M.
- Renaissance Technologies fully exited Apple in Q3 2018, selling an estimated $707M.
- Renaissance Technologies's ten largest holdings make up 9.7% of its $97.3B portfolio in Q3 2018.
- Renaissance Technologies opened 508 new positions and closed 410 in Q3 2018.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $97.3B.
Based on Renaissance Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.